Allsino Pharmaceutical Co. Ltd

Allsino Pharmaceutical, established in May 2004, spans 97,350m² and specializes in the R&D and manufacturing of RSMs, GMP intermediates, and APIs. Our products are primarily exported to the U.S., Europe, Japan, and other developed regions. Certified by ISO and evaluated by NMPA for GMP compliance, we offer high-quality R&D and production services to global pharmaceutical companies. Our large-scale production facility includes 10 chemical synthesis workshops, 1 hydrogenation workshop, and 5 API GMP workshops, equipped with 432 reactors with a total volume of 1,424.8 m².